About medicatrade
Overview
Medicatrade is a forex and CFD broker established on 26 September 2021 and registered in China. The broker presents itself as a multi-asset trading platform, offering access to forex, digital currencies, stocks, indices, and commodities.
The broker’s domain, medicatrade.cc, is its primary online presence, and it currently operates without any known regulatory licences from major financial authorities. This lack of oversight is a significant factor for potential clients to consider when evaluating the broker's credibility and the safety of their funds.
Regulation and Safety
According to our records, medicatrade does not hold any regulatory licences from established bodies such as the FCA, CySEC, ASIC, or other recognised regulators. The absence of regulation means that traders have no external recourse in the event of disputes or broker misconduct.
FXCanary has assigned medicatrade a Scam Risk Score of 54 out of 100, indicating an elevated risk level. This score reflects the combination of no regulatory oversight, limited operational history, and low public information transparency.
Account Types and Trading Conditions
Medicatrade offers five distinct account tiers: White Belt, Orange Belt, Blue Belt, Black Belt, and Red Belt Master. The account types are structured with varying maximum leverage levels, though specific minimum deposit requirements are not provided.
The lowest tiers (White Belt and Orange Belt) offer maximum leverages of 1:500 and 1:400 respectively, while the higher tiers do not have specified leverage limits. This tier structure suggests the broker aims to cater to both novice and more experienced traders, but the lack of full details on conditions like spreads and commissions makes comparison difficult.
Instruments and Platforms
The broker claims to offer trading in multiple asset classes, including forex, digital currencies, stocks, indices, and commodities. No information is available on the trading platform used (e.g., MetaTrader 4/5, proprietary platform) or any additional tools.
Potential clients should seek clarification on these technical aspects before committing funds, as platform functionality can significantly impact trading experience. Without third-party confirmation, the broker's claims about available instruments remain unverified.
Company Background
Medicatrade was founded in Q3 2021 and is registered in China. The broker’s limited operational history of less than three years means there is little track record to assess its reliability or longevity.
No information is available about the company’s management team, physical address, or any corporate registrations. This lack of transparency further elevates the risk profile for traders considering this broker.
Funding Methods
Specific deposit and withdrawal methods are not disclosed by medicatrade. Without this information, traders cannot evaluate the convenience, speed, or cost of funding their accounts.
Additionally, the absence of clear details on account currencies and handling fees makes it difficult to estimate the overall cost of trading with this broker. Traders are advised to request this information directly from the broker before opening an account.
Target Audience
Medicatrade appears to target retail traders seeking high-leverage trading across a range of assets. The belt-themed account tiers may appeal to individuals who prefer a gamified or progressive account structure.
However, given the elevated risk score and lack of regulation, this broker is more suitable for traders who fully understand the risks involved and are willing to accept the absence of regulatory safeguards. It is not recommended for conservative investors or those prioritising fund security.
Overview compiled by FXCanary from regulatory records and public data. full medicatrade review